Journal Mobile Options
Table of Contents
Vol. 56, No. 5, 1992
Issue release date: 1992
Section title: Original Paper
Neuroendocrinology 1992;56:742–749
(DOI:10.1159/000126302)

Placental Corticotropin-Releasing Hormone and Pituitary-Adrenal Function during Pregnancy

Goland R.S. · Conwell I.M. · Warren W.B. · Wardlaw S.L.
Departments of Medicine and Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, N.Y., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 2/3/1992
Accepted: 4/9/1992
Published online: 4/7/2008

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)

For additional information: http://www.karger.com/NEN

Abstract

The placenta secretes large amounts of the hypothalamic releasing hormone, corticotropin-releasing hormone (CRH), into both the maternal and fetal circulation during pregnancy. We characterized the relationship between maternal plasma CRH and products of the pituitary and adrenal in order to investigate the physiologic role of placental CRH in modulating maternal pituitary-adrenal function. Plasma was obtained from 8 women at biweekly intervals between 21 and 40 weeks of full-term pregnancy for CRH, adrenocorticotropin (ACTH), α-melanocyte-stimulating hormone (α MSH), cortisol, and dehydroepiandrosterone sulfate (DHEAS) measurements by radio-immunoassay. Eighteen women were also studied once at 22-34 weeks of pregnancy with plasma CRH and 24-hour urinary free cortisol measurement. Eight nonpregnant women served as control subjects. Plasma CRH was undetectable in the nonpregnant subjects and rose over the time period studied in the pregnant women. Concentrations of afternoon ACTH and cortisol also rose during pregnancy while DHEAS levels declined in the pregnant women. The α-MSH levels were beneath the level of detection (<20 pg/ml) in both the pregnant and nonpregnant subjects. The overall mean afternoon ACTH concentration was higher in the pregnant than in the nonpregnant women (11.4 ± 1.8 vs. 5.9 ± 1.8 pg/ml; p < 0.05), although the ACTH levels in both groups remained within the normal range. The mean plasma cortisol concentrations were higher in the pregnant women, while the mean DHEAS levels were lower in the pregnant women when compared to the nonpregnant subjects. The urinary free cortisol concentration was also significantly higher in the pregnant than in the nonpregnant women (89.2 ± 14.5 vs. 29 ± 1 µg/ day; p < 0.05). The maternal plasma CRH concentration was significantly correlated with the 24-hour urinary free cortisol level (r = 0.71; p < 0.001). Thus we show that maternal plasma CRH, ACTH, cortisol, and urinary free cortisol rise during pregnancy, while plasma DHEAS declines. The present data strongly support the hypothesis that placental CRH is a physiologic regulator of the pituitary-adrenal axis and that these alterations of pituitary-adrenal function during pregnancy may be due in part to chronic placental CRH secretion.


  

Author Contacts

Robin S. Goland, MD, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 W 168th Street, New York, NY 10032 (USA)

  

Article Information

Received: February 3, 1992
Accepted after revision: April 9, 1992
Published online: April 07, 2008
Number of Print Pages : 8

  

Publication Details

Neuroendocrinology (International Journal for Basic and Clinical Studies on Neuroendocrine Relationships)

Vol. 56, No. 5, Year 1992 (Cover Date: 1992)

Journal Editor: Millar R.P. (Edinburgh)
ISSN: 0028–3835 (Print), eISSN: 1423–0194 (Online)

For additional information: http://www.karger.com/NEN


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 2/3/1992
Accepted: 4/9/1992
Published online: 4/7/2008

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)

For additional information: http://www.karger.com/NEN


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.